At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
Senna tablets +7 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
In Brief
A clinical study evaluating PillCam® COLON 2 procedure-CONTROL, Senna tablets, and 6 other interventions for Colorectal Cancer Screening. Completed, enrolled 122 participants across 6 sites.
Detailed Summary
This study is designed to determine the optimal bowel preparation regimen for PillCam® COLON 2 Capsule Endoscopy System (CCE) procedures in average risk patients. Patients will be randomized to receive one of two bowel preparation regimens prior to PillCam CCE.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer Screening
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedJun 2015
Primary CompletionJan 2016
Study CompletionFeb 2016
TodayJul 2026
First PostedJun 25, 2015
Enrollment StartMay 1, 2015
Primary CompletionJan 1, 2016
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.0 years ago
Interventions
PillCam® COLON 2 procedure-CONTROLdevice
Senna tabletsdrug
PEGdrug
Metoclopramidedrug
Erythromycindrug
SUPREP oral sulfate solutiondrug
Bisacodyldrug
SUPREP oral sulfate solution with Gastrografindrug